Image

Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

This trial will study different outreach methods to assess impact on enrollment of underrepresented minorities (specifically African Americans) to early phase cancer clinical treatment trials. Both patients and providers (those seeing enrolled patients) will be enrolled and receive the study interventions or no intervention (control arm).

Eligibility

Inclusion Criteria for Patient Subjects:

  • Aged 18 years or older
  • Self-described African American race (patients who self-describe as "more than one race" will be included)
  • Scheduled for new or consult oncology appointment at the study site
  • Scheduled for return outpatient oncology appointment at the study site with a biopsy or radiology encounter within 2 weeks prior to provider visit.
    • for prostate cancer patients: 2 or more increasing prostate specific antigen (PSA) values i the 6 months prior to visit
  • other patient identified by research team as potentially having a change in treatment

    prior to next outpatient oncology appointment at the study site

Inclusion Criteria for Provider Subjects:

  • oncology provider at study site scheduled to see patients meeting criteria above

Exclusion Criteria for Patient Subjects:

  • Estimated glomerular filtration rate (GFR) less than 30 ml/min/1.73m2 documented within last 2 months and without documented resolutions
  • Bilirubin greater than 3.0 ng/dl documented within last 2 months and without documented resolution
  • Initiated new anti-cancer therapy within last 2 months
  • Evaluated for possible enrollment/randomization in the last 2 months
  • Prior enrollment/randomization on this recruitment trial

Study details

Cancer, Malignancy, Malignant Neoplasm

NCT05886764

University of Chicago

1 June 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.